PTC Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
PTCT
CUSIP
69366J200
Type
Equity
Class
COM
Num filings
301
Total reported value, excl. options
$4.18 B
Manager Report Date Value ($000) Shares Option Type